Literature DB >> 22905063

Sub acute sclerosing pan encephalitis despite adequate vaccination.

Bhawna Malik1, Franky J Sharma, Anand Kumar Bhardwaj, Akshay Sharma.   

Abstract

Sub acute sclerosing pan encephalitis (SSPE) is a rare neurodegenerative disorder related to a persistent and aberrant measles virus infection. It is associated with poor prognosis and high mortality. We report a case of a seven- year-old boy who manifested the disease despite proper vaccination and with no documented past history of measles. The case is being reported for its atypical presentation, rarity and its possibility of occurrence in young vaccinated subjects, possibly due to undocumented pre-vaccination measles infection.

Entities:  

Keywords:  Subacute sclerosing pan encephalitis; measles; vaccine; wild type virus

Year:  2012        PMID: 22905063      PMCID: PMC3413002          DOI: 10.4066/AMJ.2012.1262

Source DB:  PubMed          Journal:  Australas Med J        ISSN: 1836-1935


  9 in total

Review 1.  Maternal antibodies, childhood infections, and autoimmune diseases.

Authors:  R M Zinkernagel
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

2.  Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis.

Authors:  S Honarmand; C A Glaser; E Chow; J J Sejvar; C P Preas; G C Cosentino; H T Hutchison; W J Bellini
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

3.  MRI findings in subacute sclerosing panencephalitis.

Authors:  B Anlar; I Saatçi; G Köse; K Yalaz
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

4.  Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure.

Authors:  P Albrecht; F A Ennis; E J Saltzman; S Krugman
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

Review 5.  Subacute sclerosing panencephalitis.

Authors:  R K Garg; B Karak; A M Sharma
Journal:  Indian Pediatr       Date:  1998-04       Impact factor: 1.411

Review 6.  Subacute sclerosing panencephalitis.

Authors:  G G Gascon
Journal:  Semin Pediatr Neurol       Date:  1996-12       Impact factor: 1.636

7.  Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.

Authors:  William J Bellini; Jennifer S Rota; Luis E Lowe; Russell S Katz; Paul R Dyken; Sherif R Zaki; Wun-Ju Shieh; Paul A Rota
Journal:  J Infect Dis       Date:  2005-10-12       Impact factor: 5.226

8.  Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.

Authors:  G Gascon; S Yamani; J Crowell; B Stigsby; M Nester; I Kanaan; A Jallu
Journal:  Brain Dev       Date:  1993 Sep-Oct       Impact factor: 1.961

Review 9.  Subacute sclerosing panencephalitis.

Authors:  Ravindra Kumar Garg
Journal:  J Neurol       Date:  2008-10-14       Impact factor: 4.849

  9 in total
  2 in total

Review 1.  Relevance of the Measles Virus Expression in Cancer - an Update.

Authors:  Daniel Benharroch; Samuel Ariad; Noa Tadmor; Karen Nalbandyan; Irena Lazarev
Journal:  Pathol Oncol Res       Date:  2016-06-10       Impact factor: 3.201

Review 2.  Subacute sclerosing panencephalitis in pregnancy.

Authors:  Michael H Chiu; Bonnie Meatherall; Ana Nikolic; Kristine Cannon; Kevin Fonseca; Jeffrey T Joseph; Judy MacDonald; Kanti Pabbaraju; Raymond Tellier; Sallene Wong; Marcus W Koch
Journal:  Lancet Infect Dis       Date:  2016-01-20       Impact factor: 25.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.